GlassScriptPhysician profile
Deneice Brannan
NPI 1093701153
$2,359.37
in general payments reported to CMS, 2019-2025
9 companies · $598 in 2025
The $598 reported for 2025 was more than what 97% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $173 · 2022: $488 · 2023: $445 · 2024: $656 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,699.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $986.63 | 2021-2025 | Entyvio, Gattex, Eohilia |
| Janssen Biotech, INC. | $757.12 | 2022-2025 | Stelara, Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $449.12 | 2021-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $36.95 | 2022 | |
| Redhill Biopharma INC. | $31.84 | 2021 | |
| Ardelyx, INC. | $29.48 | 2023 | Ibsrela |
| Braintree Laboratories, INC. | $28.95 | 2023-2024 | Sutab, Suflave |
| Abbvie INC. | $27.98 | 2022 | |
| Biosense Webster, INC. | $11.30 | 2024 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deneice Brannan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.